Rhinovirus Completed Phase 3 Trials for Nitazoxanide (DB00507)

IndicationStatusPhase
DBCOND0035950 (Rhinovirus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03605862Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus InfectionTreatment